EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Multifaceted investigations of PSMB8 provides insights into prognostic prediction and immunological target in thyroid carcinoma

Yulou Luo iD, Yinghui Ye, Yilina Saibaidoula, Yuting Zhang, Yan Chen

PLOS One · 2025

DOI: 10.1371/journal.pone.0323013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Yulou Luo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, Xinjiang Uygur Autonomous Region, China. Hauptthemen laut MEDLINE: Proteasome Endopeptidase Complex, Thyroid Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Proteasome 20S subunit beta 8 (PSMB8) is an integral element of the immunoproteasome complex, playing a pivotal role in antigen processing. Despite its significance, the contributory role of PSMB8 in oncogenesis, particularly in thyroid carcinoma (THCA), has not been well-characterized. To address this gap in knowledge, our study endeavored to delineate the potential associations between PSMB8 and THCA. Transcriptomic profiles and clinical data of patients with THCA were retrieved from The Cancer Genome Atlas (TCGA) database to facilitate comprehensive analysis. Complementary resources from additional online databases were utilized to augment the study. Logistic regression analysis was employed to elucidate the relationship between PSMB8 and various clinicopathological parameters. Uni/multivariate Cox regression analyses were conducted to ascertain the independent prognostic factors for THCA patient outcomes. Quantitative polymerase chain reaction (qPCR) and western blot assays were employed to verify the expression level of PSMB8 in vitro . Our study demonstrated that PSMB8 was significantly upregulated in THCA, with its overexpression correlating with lymph node metastasis, extrathyroidal extension, and favorable prognosis. Immunohistochemistry substantiated a higher PSMB8 protein presence in THCA tissue compared to the normal, supporting its potential role as a moderately accurate diagnostic biomarker. Logistic regression analysis identified PSMB8 as a significant indicator of the N1 stage, classical histological subtype, and extrathyroidal extension. Age, T stage, and PSMB8 were further determined as independent prognostic factors for THCA. Functional investigations linked PSMB8 to immune processes, evidenced by its association with increased immune cell infiltration and higher stromal/immune scores, as well as a positive co-expression with several immune checkpoints. A constructed predicted competing endogenous RNA (ceRNA) network implicated PSMB8 in complex post-transcriptional regulation. Finally, in vitro assays confirmed the upregulation of PSMB8, underscoring its relevance in THCA and as a target for future research. Our work has preliminarily appraised PSMB8 as a biomarker with certain prognostic and diagnostic significance, and as a potential target for immunotherapy in THCA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proteasome Endopeptidase ComplexThyroid NeoplasmsBiomarkers, TumorHumansPrognosisFemaleMaleMiddle AgedGene Expression Regulation, NeoplasticCell Line, TumorAdultAged

Substanzen

Proteasome Endopeptidase ComplexBiomarkers, TumorLMP7 protein

Autor:innen und Institutionen

  • Department of Breast Surgery, Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, Xinjiang Uygur Autonomous Region, China.
  • Department of Laboratory Medicine, Xinhua Hospital, Shenzhen, Guangdong Province, China.
  • Department of Breast Surgery, The First Affiliated Hospital, Jinan University, Guangzhou, Guangdong Province, China.
  • Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Xinjiang Medical University, Urumqi, Xinjiang Uygur Autonomous Region, China.
  • Xinjiang Key Laboratory of Molecular Biology for Endemic Diseases, Urumqi, Xinjiang Uygur Autonomous Region, China.

ORCID-Profile: Yulou Luo

Zitieren

APA

Luo, Y., Ye, Y., Saibaidoula, Y., Zhang, Y., & Chen, Y. (2025). Multifaceted investigations of PSMB8 provides insights into prognostic prediction and immunological target in thyroid carcinoma. PLOS One. https://doi.org/10.1371/journal.pone.0323013

Vancouver

Luo Y, Ye Y, Saibaidoula Y, Zhang Y, Chen Y. Multifaceted investigations of PSMB8 provides insights into prognostic prediction and immunological target in thyroid carcinoma. PLOS One. 2025. doi:10.1371/journal.pone.0323013

BibTeX
@article{Luo2025,
  author = {Luo, Yulou and Ye, Yinghui and Saibaidoula, Yilina and Zhang, Yuting and Chen, Yan},
  title = {Multifaceted investigations of PSMB8 provides insights into prognostic prediction and immunological target in thyroid carcinoma},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0323013}
}
Kostenlos starten →